Cargando…

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

BACKGROUND: Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases (HDACs) is at present undergoing clinical testing in cancer therapy. As epigenetic alterations are common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arce, Claudia, Pérez-Plasencia, Carlos, González-Fierro, Aurora, de la Cruz-Hernández, Erick, Revilla-Vázquez, Alma, Chávez-Blanco, Alma, Trejo-Becerril, Catalina, Pérez-Cárdenas, Enrique, Taja-Chayeb, Lucia, Bargallo, Enrique, Villarreal, Patricia, Ramírez, Teresa, Vela, Teresa, Candelaria, Myrna, Camargo, Maria F., Robles, Elizabeth, Dueñas-González, Alfonso
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762324/ https://www.ncbi.nlm.nih.gov/pubmed/17183730 http://dx.doi.org/10.1371/journal.pone.0000098

Ejemplares similares

A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
por: Arce, Claudia, et al.
Publicado: (2007)

Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
por: Chavez-Blanco, Alma, et al.
Publicado: (2006)

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
por: Candelaria, Myrna, et al.
Publicado: (2007)

Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
por: Chavez-Blanco, Alma, et al.
Publicado: (2005)

DNA Methylation-Independent Reversion of Gemcitabine Resistance by Hydralazine in Cervical Cancer Cells
por: Candelaria, Myrna, et al.
Publicado: (2012)

Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study
por: Candelaria, Myrna, et al.
Publicado: (2007)

Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome
por: Taja-Chayeb, Lucia, et al.
Publicado: (2009)

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
por: Zambrano, Pilar, et al.
Publicado: (2005)

Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine
por: Segura-Pacheco, Blanca, et al.
Publicado: (2006)

Hydralazine target: From blood vessels to the epigenome
por: Arce, Claudia, et al.
Publicado: (2006)

Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells
por: Pérez-Cárdenas, Enrique, et al.
Publicado: (2018)

Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
por: Taja-Chayeb, Lucia, et al.
Publicado: (2006)

HER2 expression in cervical cancer as a potential therapeutic target
por: Chavez-Blanco, Alma, et al.
Publicado: (2004)

Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model
por: Trejo-Becerril, Catalina, et al.
Publicado: (2016)

Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
por: Trejo-Becerril, Catalina, et al.
Publicado: (2012)

Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
por: Trejo-Becerril, Catalina, et al.
Publicado: (2005)

Polymorphisms of the thiopurine methyl transferase gene in healthy and acute lymphoblastic leukemia mestizos
por: Candelaria, Myrna, et al.
Publicado: (2007)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021)

Adriamycin-Cyclophosphamide (AC) followed by Paclitaxel-Cisplatin (PC). A highly active neoadjuvant regimen in locally advanced breast cancer
por: Mendoza-Posada, Daniel, et al.
Publicado: (2007)

Molecular characterization of BRCA1 and BRCA2 genes in breast cancer patients under 40 years-old or with familiar cancer history
por: Millan, Silvia Vidal, et al.
Publicado: (2007)

ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma
por: Díaz-Chávez, José, et al.
Publicado: (2022)

A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells
por: Schcolnik-Cabrera, Alejandro, et al.
Publicado: (2020)

Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?
por: Gonzalez-Fierro, Aurora, et al.
Publicado: (2023)

Epigenetics of cervical cancer. An overview and therapeutic perspectives
por: Dueñas-González, Alfonso, et al.
Publicado: (2005)

The prince and the pauper. A tale of anticancer targeted agents
por: Dueñas-González, Alfonso, et al.
Publicado: (2008)

Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy?
por: Perez-Plasencia, Carlos, et al.
Publicado: (2006)

Radiosensitizers in cervical cancer. Cisplatin and beyond
por: Candelaria, Myrna, et al.
Publicado: (2006)

Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction
por: Cetina, Lucely, et al.
Publicado: (2007)

The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study
por: de la Cruz-Hernández, Erick, et al.
Publicado: (2007)

Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway
por: Perez-Plasencia, Carlos, et al.
Publicado: (2008)

Adhesive Resins with High Shelf-Life Stability Based on Tetra Unsaturated Monomers with Tertiary Amines Moieties
por: Pérez-Mondragón, Alma Antonia, et al.
Publicado: (2021)

Tamoxifen-associated vasculitis in a breast cancer patient
por: Candelaria, Myrna, et al.
Publicado: (2007)

Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular
por: Reynoso-Noverón, Nancy, et al.
Publicado: (2017)

Prevalence of Thyroid Autoimmunity in Women with Recurrent Pregnancy Loss
por: Godines-Enriquez, Myrna Souraye, et al.
Publicado: (2021)

Metabolic tumor volume changes assessed by interval (18)fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma
por: Oñate-Ocaña, Luis F., et al.
Publicado: (2018)

Alternative splicing regulation in tumor necrosis factor-mediated inflammation
por: López-Urrutia, Eduardo, et al.
Publicado: (2017)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
por: López-Urrutia, Eduardo, et al.
Publicado: (2021)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)

Selective Acetogenins and Their Potential as Anticancer Agents
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2019)

Infusión de ketamina para disminuir los requerimientos anestésicos y analgésicos en pacientes programados para cirugía abdominal
por: Merlos Becerril, Alma Delia
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_krde7u2ahc98svns41etap0g0g